Cancer research in the SARS-CoV pandemia
Keywords:
cancer, coronavirus infections
Downloads
Download data is not yet available.
References
1. World Health Organization. Novel coronavirus (2019-nCoV) situation report N° 1 – 1. Geneva: World Health Organization; 2020.
2. World Health Organization. Coronavirus disease (COVID-19). Report No. 124. Geneva: World Health Organization; 2020.
3. Manchein C, Brugnago EL, Silva RM, Mendes CF, Beims MW. Strong correlations between power-law growth of COVID-19 in four continents and the inefficiency of soft quarantine strategies. Chaos. 2020;30:041102. https://doi.org/10.1063/5.0009454
4. World Health Organization. Coronavirus disease (COVID-19). Dashboard. Geneva: World Health Organization; 2020.
5. World Health Organization. COVID-19. Global literature on coronavirus disease. Geneva: World Health Organization; 2020.
6. Organización Panamericana de la Salud. Consideraciones para la reorganización de los servicios oncológicos durante la pandemia de COVID-19. Washington, D.C.: Organización Panamericana de la Salud; 2020.
7. Dinmohamed AG, Visser O, Verhoeven RHA, Louwman MWJ, van Nederveen FH, Willems SM, et al. Fewer cancer diagnoses during the COVID-19 epidemic in the Netherlands. Lancet Oncol. 2020;S1470-2045(20)30265-5. https://doi.org/10.1016/S1470-2045(20)30265-5
8. Lai A, Pasea L, Banerjee A, Denaxas S, Katsoulis M, Chang WH, et al. Estimating excess mortality in people with cancer and multimorbidity in the COVID-19 emergency. medRxiv. 2020. https://doi.org/10.1101/2020.05.27.200832
9. Gosain R, Abdou Y, Singh A, Rana N, Puzanov I, Ernstoff MS. COVID-19 and cancer: A comprehensive review. Curr Oncol Rep. 2020;22:53. https://doi.org/10.1007/s11912-020-00934-7. 10. Managing cancer during a pandemic. Nat Rev Clin Oncol. 2020;17:267. https://doi.org/10.1038/s41571-020-0365-3
11. Yu J, Ouyang W, Chua MLK, Xie C. SARS-CoV-2 Transmission in patients with cancer at a tertiary care hospital in Wuhan, China. JAMA Oncol. 2020;e200980.
https://doi.org/10.1001/jamaoncol.2020.0980
12. Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al. Presenting characteristics, comorbidities, and outcomes among 5,700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020;323:2052-9. https://doi.org/10.1001/jama.2020.6775
13. Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, et al. Baseline characteristics and outcomes of 1,591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy. JAMA. 2020;323:1574-81. https://doi.org/10.1001/jama.2020.5394
14. Boulad F, Kamboj M, Bouvier N, Mauguen A, Kung AL. COVID-19 in children with cancer in New York City. JAMA Oncol. 2020;e202028. https://doi.org/10.1001/jamaoncol.2020.2028
15. Kuderer NM, Choueiri TK, Shah DP, Shyr Y, Rubinstein SM, Rivera DR, et al. Clinical impact of COVID-19 on patients with cancer (CCC19): A cohort study. Lancet. 2020;S0140-6736(20)31187-9. https://doi.org/10.1016/S0140-6736(20)31187-9
16. Liang W, Guan W, Chen R, Wang W, Li J, Xu K, et al. Cancer patients in SARS-CoV-2 infection: A nationwide analysis in China. Lancet Oncol. 2020;21:335-7.
https://doi.org/10.1016/S1470-2045(20)30096-6
17. Instituto de Evaluación de Tecnologías, Asociación Colombiana de Infectología. Consenso colombiano de atención, diagnóstico y manejo de la infección SARS COVID-19 en establecimientos de atención en salud. Recomendaciones basadas en consenso de expertos e informadas en la evidencia. Infectio. 2020;4:1-153. https://doi.org/10.22354/in.v24i3.851
18. Zhang L, Zhu F, Xie L, Wang C, Wang J, Chen R, et al. Clinical characteristics of COVID-19-infected cancer patients: A retrospective case study in three hospitals within Wuhan, China. Ann Oncol. 2020;S0923-7534(20)36383-3. https://doi.org/10.1016/j.annonc.2020.03.296
19. Robert GU, Alexander K, Daniel M G. Coronavirus disease 2019 (COVID-19). Cancer care during the pandemic. Fecha de consulta: 28 de mayo de 2020. Disponible en: https://www.uptodate.com/contents/coronavirus-disease-2019-covid-19-cancer-care-during-the-pandemic
20. Al-Shamsi HO, Coomes EA, Alrawi S. Screening for COVID-19 in asymptomatic patients with cancer in a hospital in the United Arab Emirates. JAMA Oncol. 2020.
https://doi.org/10.1001/jamaoncol.2020.2548
2. World Health Organization. Coronavirus disease (COVID-19). Report No. 124. Geneva: World Health Organization; 2020.
3. Manchein C, Brugnago EL, Silva RM, Mendes CF, Beims MW. Strong correlations between power-law growth of COVID-19 in four continents and the inefficiency of soft quarantine strategies. Chaos. 2020;30:041102. https://doi.org/10.1063/5.0009454
4. World Health Organization. Coronavirus disease (COVID-19). Dashboard. Geneva: World Health Organization; 2020.
5. World Health Organization. COVID-19. Global literature on coronavirus disease. Geneva: World Health Organization; 2020.
6. Organización Panamericana de la Salud. Consideraciones para la reorganización de los servicios oncológicos durante la pandemia de COVID-19. Washington, D.C.: Organización Panamericana de la Salud; 2020.
7. Dinmohamed AG, Visser O, Verhoeven RHA, Louwman MWJ, van Nederveen FH, Willems SM, et al. Fewer cancer diagnoses during the COVID-19 epidemic in the Netherlands. Lancet Oncol. 2020;S1470-2045(20)30265-5. https://doi.org/10.1016/S1470-2045(20)30265-5
8. Lai A, Pasea L, Banerjee A, Denaxas S, Katsoulis M, Chang WH, et al. Estimating excess mortality in people with cancer and multimorbidity in the COVID-19 emergency. medRxiv. 2020. https://doi.org/10.1101/2020.05.27.200832
9. Gosain R, Abdou Y, Singh A, Rana N, Puzanov I, Ernstoff MS. COVID-19 and cancer: A comprehensive review. Curr Oncol Rep. 2020;22:53. https://doi.org/10.1007/s11912-020-00934-7. 10. Managing cancer during a pandemic. Nat Rev Clin Oncol. 2020;17:267. https://doi.org/10.1038/s41571-020-0365-3
11. Yu J, Ouyang W, Chua MLK, Xie C. SARS-CoV-2 Transmission in patients with cancer at a tertiary care hospital in Wuhan, China. JAMA Oncol. 2020;e200980.
https://doi.org/10.1001/jamaoncol.2020.0980
12. Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al. Presenting characteristics, comorbidities, and outcomes among 5,700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020;323:2052-9. https://doi.org/10.1001/jama.2020.6775
13. Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, et al. Baseline characteristics and outcomes of 1,591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy. JAMA. 2020;323:1574-81. https://doi.org/10.1001/jama.2020.5394
14. Boulad F, Kamboj M, Bouvier N, Mauguen A, Kung AL. COVID-19 in children with cancer in New York City. JAMA Oncol. 2020;e202028. https://doi.org/10.1001/jamaoncol.2020.2028
15. Kuderer NM, Choueiri TK, Shah DP, Shyr Y, Rubinstein SM, Rivera DR, et al. Clinical impact of COVID-19 on patients with cancer (CCC19): A cohort study. Lancet. 2020;S0140-6736(20)31187-9. https://doi.org/10.1016/S0140-6736(20)31187-9
16. Liang W, Guan W, Chen R, Wang W, Li J, Xu K, et al. Cancer patients in SARS-CoV-2 infection: A nationwide analysis in China. Lancet Oncol. 2020;21:335-7.
https://doi.org/10.1016/S1470-2045(20)30096-6
17. Instituto de Evaluación de Tecnologías, Asociación Colombiana de Infectología. Consenso colombiano de atención, diagnóstico y manejo de la infección SARS COVID-19 en establecimientos de atención en salud. Recomendaciones basadas en consenso de expertos e informadas en la evidencia. Infectio. 2020;4:1-153. https://doi.org/10.22354/in.v24i3.851
18. Zhang L, Zhu F, Xie L, Wang C, Wang J, Chen R, et al. Clinical characteristics of COVID-19-infected cancer patients: A retrospective case study in three hospitals within Wuhan, China. Ann Oncol. 2020;S0923-7534(20)36383-3. https://doi.org/10.1016/j.annonc.2020.03.296
19. Robert GU, Alexander K, Daniel M G. Coronavirus disease 2019 (COVID-19). Cancer care during the pandemic. Fecha de consulta: 28 de mayo de 2020. Disponible en: https://www.uptodate.com/contents/coronavirus-disease-2019-covid-19-cancer-care-during-the-pandemic
20. Al-Shamsi HO, Coomes EA, Alrawi S. Screening for COVID-19 in asymptomatic patients with cancer in a hospital in the United Arab Emirates. JAMA Oncol. 2020.
https://doi.org/10.1001/jamaoncol.2020.2548
How to Cite
1.
Wiesner C. Cancer research in the SARS-CoV pandemia. Biomed. [Internet]. 2020 Jun. 15 [cited 2025 Apr. 5];40(2):217-9. Available from: https://revistabiomedicaorg.biteca.online/index.php/biomedica/article/view/5691
Some similar items:
- José Moreno-Montoya, The challenge of communicating and controlling the coronavirus epidemic , Biomedica: Vol. 40 No. 1 (2020)
- Juan Pimentel, Neil Andersson, Chloroquine and its derivatives in the management of COVID-19: A scoping review , Biomedica: Vol. 40 No. Supl. 2 (2020): SARS-CoV-2 y COVID-19
- Alejandro Martí , Sarai Morón, Eliana González , Julián Rojas , Incidental findings of COVID-19 in F18-FDG PET/CT from asymptomatic patients with cancer in two healthcare institutions in Bogotá, Colombia , Biomedica: Vol. 40 No. Supl. 2 (2020): SARS-CoV-2 y COVID-19
- Marco Torres-Castro, Biol. Naomi Cuevas, Dra. Silvia Hernández, IBQ. Henry Noh, Biol. Erendira Estrella, M. en C. Belén Herrera, Dr. Alonso Panti, Dr. Etienne Waleckx, M. en C. Javier Sosa, Dr. Ronald Peláez, Natural infection with Trypanosoma cruzi in bats captured in Campeche and Yucatán, México , Biomedica: Vol. 41 No. Supl. 1 (2021): Mayo, Parasitología médica
- Carolina Rivero-Rubio, Angélica I. Navarro-Rodríguez, María C. Castro-Reyes, Oscar Araujo-Quintana, José Moreno-Montoya, Jesús A. Estevez-García, Pablo A. Martínez-Silva, Álvaro J. Idrovo, Claudia Amaya-Castellanos, Health conditions of Hitnü indigenous people potentially exposed to crude oil in Arauca, Colombia , Biomedica: Vol. 42 No. 4 (2022)
- Patricia Escandón, Shawn R. Lockhart, Nancy A. Chow, Tom M. Chiller, Candida auris: a global pathogen that has taken root in Colombia , Biomedica: Vol. 43 No. Sp. 1 (2023): Agosto, Micología médica
- Sandra Aruachan Vesga, Manuel González , Danis M. Rojas, Javier Ospina, Santiago Varela, Andrés Castaño , Avoided costs to the Colombian health system due to the implementation of externally funded oncology clinical trials , Biomedica: Vol. 45 No. 1 (2025): Publicación anticipada
Published
2020-06-15
Issue
Section
Editorial
| Article metrics | |
|---|---|
| Abstract views | |
| Galley vies | |
| PDF Views | |
| HTML views | |
| Other views | |
